GO
Loading...

Biogen Idec Inc

More

  • Market Insider: Thursday Look Ahead Wednesday, 18 Jun 2008 | 8:02 PM ET

    High oil prices and a wary skittishness among traders keeps the pressure on stocks going into Thursday's session.

  • Now we bring you even more Fast ways to trade tomorrow's market moving events. Also Jon Najarian's options action trade!

  • Shareholder Discontent at Biogen, Yahoo, CSX Tuesday, 10 Jun 2008 | 12:44 PM ET

    ISS recommends a vote against dissident slate and looks ahead to CSX' shareholder meeting.

  • Biotech’s Biggest Weekend Wednesday, 28 May 2008 | 6:27 PM ET

    With the ASCO conference beginning Friday new cancer drugs are likely to grab headlines. How should you trade ahead of biotech’s biggest weekend?

  • Icahn To Go Behind-The-Scenes At Biogen Idec Wednesday, 21 May 2008 | 4:41 PM ET

    So, Carl Icahn is grabbing headlines this week over his new battle with Yahoo and how Boone Pickens is backing him up now, too. But Icahn has his finger in a lot of pies. He's still in a proxy fight with Biogen Idec where he's trying to get his people on the Board at the upcoming shareholder meeting on June 19th.

  • Your First Move For Wednesday Apr. 30th Tuesday, 29 Apr 2008 | 6:47 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Tech Gains Boost Nasdaq; Airlines Rise Tuesday, 29 Apr 2008 | 5:04 PM ET

    Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.

  • Stocks Turn Higher; Airlines Rise Tuesday, 29 Apr 2008 | 2:55 PM ET

    Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.

  • Merck Drags on Dow; Airline Stocks Rise Tuesday, 29 Apr 2008 | 2:44 PM ET

    Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.

  • Genentech, Biogen Idec Shares Hit by Study Results Tuesday, 29 Apr 2008 | 12:07 PM ET

    Genentech and Biogen Idec said a key study of Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.

  • Merck "Adapts" To Tredaptive Setback Tuesday, 29 Apr 2008 | 11:37 AM ET

    Investors are finding no solace in Merck's reaffirmation that it'll still hit its earnings numbers this year. Instead they're punishing the stock after the company announced what everyone is calling a surprise and a significant setback.

  • Bitter Pill? Friday, 18 Apr 2008 | 6:28 PM ET

    Was Pfizer's miss, a prescription for disaster in Big Pharma? Should you sell drug makers ahead of earnings next week?

  • Dendreon's Secret "Lover" Finally Revealed Tuesday, 15 Apr 2008 | 11:04 AM ET

    It's not Carl Icahn. Earlier this month I blogged about a mysterious institutional investor taking a big stake in the ever-popular biotech Dendreon. DNDN's CFO was quoted as saying the secret admirer was familiar with biotech leading some to speculate it might be the billionaire activist investor who has taken stakes in Biogen-Idec, MedImmune and ImClone, just to name a few.

  • Genentech Earnings Preview: Cure for Portfolio Ills? Thursday, 10 Apr 2008 | 1:37 PM ET
    Genetech

    Genentech stock is on a tear this year and analysts are expecting double-digit sales growth for most of the biotech's key drugs this quarter. Can Genentech keep it up?

  • Triage Trade: Pfizer Wednesday, 9 Apr 2008 | 6:33 PM ET

    Pfizer treats us for everything from high cholesterol to impotence but in an ironic twist, it’s very sick itself. What’s the prescription for getting shares of Pfizer out of triage?

  • Buy Research in Motion Monday, 24 Mar 2008 | 3:48 PM ET

    With a strong quarter expected next week, the shorts are on the run.

  • Next Weeks Trades: Wal-Mart, Costco & More Friday, 7 Mar 2008 | 7:28 PM ET

    In Friday’s Web Extra find out how the traders recommend playing Wal-Mart, Costco, Pfizer, Amgen and Genentech in the week ahead.

  • Analyst: Pfizer Should Buy Amgen or Wyeth Friday, 7 Mar 2008 | 10:48 AM ET

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...

  • Baxter, Biogen Idec & Elan Subjects of Broken Embargoes Wednesday, 5 Mar 2008 | 8:15 AM ET

    Embargoes imposed by scientific groups and medical journals will once again be put to the test over the next couple of months.

  • Best Rally of the Year Stalls Wednesday, 27 Feb 2008 | 6:29 PM ET

    Bernanke hinted at more rate cuts in his testimony to Congress, the dollar sunk to a new all-time low and Apple jumped higher after hours. Get the day's biggest stories right here.